MedTrace Logo

Digital Patient Support Program for Self-efficacy and Medication Adherence in Women on Adjuvant Endocrine Treatment for Breast Cancer

NCT06989450 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 140

Last updated 2025-05-25

No results posted yet for this study

Summary

This is a randomized, controlled study to assess the effect of Sidekick Health's digital program on self-efficacy and medication adherence in breast cancer patients prescribed adjuvant anti-hormonal treatment. Participants will be treated with the digital program in addition to standard of care (SoC), or SoC only.

Conditions

Interventions

DEVICE

Sidekick digital patient support program for patients with breast cancer

A digital health program delivered through an app that provides holistic lifestyle intervention and medication adherence support.

OTHER

Standard of care for breast cancer patients

Standard of care includes adjuvant breast cancer treatment and optional cancer rehabilitation

Sponsors & Collaborators

  • Landspitali University Hospital

    collaborator OTHER

  • University of Iceland

    collaborator OTHER

  • Icelandic Research Center

    collaborator UNKNOWN

  • Sidekick Health

    lead INDUSTRY

Principal Investigators

  • Olof Kristjana Bjarnadottir, MD, PhD · Landspitali University Hospital

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-05-31
Primary Completion
2026-06-30
Completion
2026-12-30

Countries

  • Iceland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06989450 on ClinicalTrials.gov